Cite

HARVARD Citation

    Goadsby, P. et al. (2019). Safety and tolerability of ubrogepant following intermittent, high-frequency dosing: Randomized, placebo-controlled trial in healthy adults. Cephalalgia. pp. 1753-1761. [Online]. 
  
Back to record